These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11038121)

  • 1. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.
    Chandy T; Das GS; Rao GH
    J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cisplatin delivery due to surface-coated poly (lactic acid)-poly(epsilon-caprolactone) microspheres.
    Chandy T; Wilson RF; Rao GH; Das GS
    J Biomater Appl; 2002 Apr; 16(4):275-91. PubMed ID: 12099508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies.
    Das GS; Rao GH; Wilson RF; Chandy T
    Drug Deliv; 2000; 7(3):129-38. PubMed ID: 10989913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) microspheres.
    Das GS; Rao GHR ; Wilson RF; Chandy T
    J Biomed Mater Res; 2001 Apr; 55(1):96-103. PubMed ID: 11426403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
    Chandy T; Rao GH; Wilson RF; Das GS
    Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
    Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
    Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: characterization and drug release.
    Blanco MD; Sastre RL; Teijón C; Olmo R; Teijón JM
    J Microencapsul; 2005 Sep; 22(6):671-82. PubMed ID: 16401582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer.
    Hussain M; Beale G; Hughes M; Akhtar S
    Int J Pharm; 2002 Mar; 234(1-2):129-38. PubMed ID: 11839444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
    Boisdron-Celle M; Menei P; Benoit JP
    J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
    Lin Y; Li Y; Ooi CP
    J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
    Ciftci K; Hincal AA; Kas HS; Ercan TM; Sungur A; Guven O; Ruacan S
    Pharm Dev Technol; 1997 May; 2(2):151-60. PubMed ID: 9552441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil loaded chitosan microspheres for chemoembolization.
    Denkbaş EB; Seyyal M; Pişkin E
    J Microencapsul; 1999; 16(6):741-9. PubMed ID: 10575626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and release characteristics of polymer-coated and blended alginate microspheres.
    Lee DW; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2003; 20(2):179-92. PubMed ID: 12554373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and release efficiency of polylactic acid nanoparticle].
    Huang KH; Zhu ZH; Liu JH; Chen QK; Liu XY; Chang J
    Ai Zheng; 2005 Aug; 24(8):1023-6. PubMed ID: 16086887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles.
    Yeh MK; Tung SM; Lu DW; Chen JL; Chiang CH
    J Microencapsul; 2001; 18(4):507-19. PubMed ID: 11428679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.